Search results
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High Following Analyst Upgrade
ETF DAILY NEWS· 16 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during mid-day trading ...
Oracle Alpha Inc. Buys New Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 3 days agoOracle Alpha Inc. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report ...
Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...
ETF DAILY NEWS· 2 days agoTeachers Retirement System of The State of Kentucky cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past...
Simply Wall St. via Yahoo Finance· 4 days agoBut on a lighter note, a good company can see its share price rise well over 100%. Long term ...
RBC lifts Regeneron stock PT to $1,229 on higher sales estimetes of Dupixent By Investing.com
Investing.com· 6 days agoOn Wednesday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw an increase in its price target to...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 9 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) Director Michael S. Brown has completed...
...Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - Regeneron...
Benzinga· 3 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 6 days agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
TipRanks via Yahoo Finance· 5 days agoFor value investors looking to take a “break” from the euphoric technology stocks, many of which may...
Regeneron holds Buy rating and price target from TD Cowen By Investing.com
Investing.com· 4 days agoOn Friday, TD (TSX:TD) Cowen maintained a Buy rating on shares of Regeneron (NASDAQ:REGN)...